A new report has blasted the government’s response to the coronavirus pandemic and suggests the U.S. should cut ties with the World Health Organization ...

The sheer numbers of people sickened by Covid quickly made visible rare events that otherwise would have taken far longer to come to light, he added, pointing to this aberrant immune response and ...

On Thursday, three years and 100 days after the Trump administration declared the coronavirus a public health emergency, the Biden administration will allow the emergency declaration to expire ...

The findings may also be linked to an observation made early in the pandemic: Men were much more likely to die from a runaway immune response than women after contracting the COVID-19 virus.Even mild ...

The nonpartisan Covid Crisis Group has released its investigative report, titled "Lessons from the Covid War: An Investigative Report." This is what it found.

He was the husband of Céline Gounder, an infectious disease specialist and Kaiser Health News editor-at-large, who also served on President Biden’s covid-19 advisory board during the ...

COVID-19 can alter the way the immune system works, possibly contributeing to Long COVID symptoms. ... This recall, and the response it generates, can last for at least a year after infection.

Covid Has Left Deep Wounds in America’s Rural Communities The virus tore at the bonds of solidarity in rural areas like Vermont’s Northeast Kingdom. Many of the scars have yet to heal.

He recovered after a 43-day hospitalization for COVID-19 in 2020, but then developed an irregular heartbeat two months later and breathing and balance problems that still plague him today.

In the earliest days of the pandemic, Dr. Ashish Jha emerged as an authoritative and trusted voice on the issue. He's now the White House COVID-19 response coordinator, but with the public health ...

The Covid-19 public health emergency will end on May 11, and the Washington Post first reported that date could lead to a formal unwinding of the White House Covid-19 response team.

A rebound of COVID-19 symptoms in some patients after taking Pfizer's antiviral Paxlovid may be related to a robust immune response rather than a weak one, U.S. government researchers reported on ...